FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer.

Autor:	Oliveira, M1,2,3 (AUTHOR) moliveira@vhio.net, Saura, C1,2,3 (AUTHOR), Nuciforo, P4 (AUTHOR), Calvo, I5 (AUTHOR), Andersen, J6 (AUTHOR), Passos-Coelho, J L7 (AUTHOR), Gil, M Gil3,8,9 (AUTHOR), Bermejo, B10 (AUTHOR), Patt, D A11 (AUTHOR), Ciruelos, E3,12 (AUTHOR), Peña, L de la3 (AUTHOR), Xu, N13 (AUTHOR), Wongchenko, M14 (AUTHOR), Shi, Z14 (AUTHOR), Singel, S M13 (AUTHOR), Isakoff, S J15 (AUTHOR)
Zdroj:	Annals of Oncology. Aug2019, Vol. 30 Issue 8, p1289-1297. 9p. 2 Charts, 4 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu